Don't let it get away!
Keep track of the stocks that matter to you.
Help yourself with the Fool's FREE and easy new watchlist service today.
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of USANA Health Sciences (NYSE: USNA ) have gained 10%, after rising throughout the day, in response to a strong earnings report and positive forward guidance.
So what: USANA reported fourth-quarter revenue of $168.5 million, and earnings of $1.27 per share, both results beating analyst expectations of $165.6 million, and $1.21 per share. Operating cash flow was also strong, with a $29.2 million result. The company offered guidance for the upcoming year of $700 million to $720 million in annual revenue, and adjusted 2013 EPS of $5.10 to $5.25. USANA's EPS guidance came in well in advance of the $4.84 that Wall Street was looking for, and the Street's top-line projection of $701.6 million hit the low end of the company's guidance range.
Now what: USANA's results offer a firm rebuttal to the bear attack led by Bill Ackman on fellow multilevel marketing company Herbalife (NYSE: HLF ) that sank many stocks in the sector at the end of last year. USANA is enjoying its best growth in China and Southeast Asia, where a 17.4% rise in the number of active Associates drove 21.3% greater sales. The company has nearly 60% of its float shorted at the moment, which could result in further short squeezes in the near future -- but it's also bound to make this stock volatile in either direction. Are you ready for a wild ride?
Want more news and updates? Add USANA Health Sciences to your Watchlist now.
The Motley Fool's chief investment officer has selected his number one stock for the next year. Find out which stock it is in our brand-new free report, "The Motley Fool's Top Stock for 2013." I invite you to take a copy, free for a limited time. Just click here to access the report and find out the name of this under-the-radar company.